Skip to content

Sideritis Supplementation and Performance

The Effect of Sideritis as Supplement on Performance

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07555288
Enrollment
12
Registered
2026-04-29
Start date
2026-04-25
Completion date
2026-05-30
Last updated
2026-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Athletic Performance

Keywords

sideritis, Extract, Performance, Blood lactate, Blood Glusose

Brief summary

The purpose of this study is to examine the effect of sideritis consumption on physiological and performance indicators in adult subjects and compare it with the control trial.

Detailed description

Significance of the Study: There is currently no evidence supporting an improvement in athletic performance following the use of sideritis. Despite existing studies showing that the mechanism through which sideritis acts is almost identical to that of other supplements that have been found to enhance athletic performance, direct evidence for its effectiveness remains lacking. Methodology: Initially, the participants of the study will visit the laboratory in order to be informed about the exercise research protocol. During the first visit, the participants will perform a maximal oxygen uptake (VO₂max) test on a treadmill using the RAMP protocol. In this specific method for determining maximal oxygen uptake, the treadmill speed will increase by 1 km/h every minute. Thus, the participants will reach exhaustion gradually. The participants will visit the laboratory two more times in order to perform the exercise protocols. One hour before each session, each participant will receive a dietary supplement, which will contain either 950 mg of sideritis or a specific dosage of a neutral substance (placebo). The selection of supplements will be random, as the study will be conducted using a double-blind design. This means that neither the participants nor the researcher will know which type of supplement has been consumed prior to the exercise protocol. The exercise protocol will consist of 60 minutes of treadmill running at an intensity of 70-75% of VO₂max, which has been individually determined for each participant based on the prior VO₂max test. During these 60 minutes, a gas exchange mask will be used to determine that participants are running at the specified intensity. After the 60 minutes, participants will wear the mask again and will run at a higher intensity (90-95% VO₂max) until exhaustion (Time to Exhaustion). Before each exercise protocol, and at 15, 30, 45, and 60 minutes during exercise, as well as immediately after completion, capillary blood samples will be collected to assess lactate and glucose levels. Additionally, body composition measurements will be conducted using the BIA method. Participants' dietary intake will also be recorded for the day prior to the VO₂max test, as well as for the days preceding the exercise protocol sessions. This recording will be conducted in order to determine whether any participant has consumed sideritis through their diet prior to the protocol. Statistical Analysis A 2-way repeated measures ANOVA will be performed. The statistical program SPSS 26 will be used.

Interventions

DIETARY_SUPPLEMENT950 mg of Sideritis Scardica (SidTea+) extract one hour pre-exercise

950 mg of Sideritis Scardica (SidTea+) extract one hour pre-exercise during exercise day

DIETARY_SUPPLEMENT950 mg of placebo one hour pre-exercise

950 mg of placebo one hour pre-exercise during exercise day

Sponsors

University of Thessaly
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy Individuals aged 18-40 years

Exclusion criteria

* Musculoskeletal Injury * Dietary supplements * Medication

Design outcomes

Primary

MeasureTime frameDescription
Change in Blood lactateChange from baseline to 15, 30, 45, 60 minutes during exercise and immediately post-exerciseBlood lactate concentration will be estimated using an analyzer.
Change in mean respiratory quotient during exerciseMean respiratory quotient will be measured during 60 minute of exerciseThe mean respiratory quotient during exercise will be measured using a gas analyzer
Change in mean oxygen consumption during exerciseMean oxygen consumption will be measured during 60 minute of exerciseMean oxygen consumption during exercise will be measured using a gas analyzer
Change in mean Heart rate during exerciseMean heart rate will be measured during 60 minute of exerciseMean heart rate during exercise will be measured using a heart rate monitor
Change in time to exhaustionThe time to exhaustion will be measured immediately after 60 minute of exerciseTime to exhaustion will be estimated using an electronic timer
Change in Glucose concentrationChange from baseline to 15, 30, 45, 60 minutes during exercise and immediately post-exerciseGlucose concentration will be estimated using an analyzer.
Change in heart rateChange from baseline to 15, 30, 45, 60 minutes during exercise and immediately post-exerciseHeart rate will be estimated using monitor units.
Change in oxygen consumptionChange from baseline to 15, 30, 45, 60 minutes during exercise and immediately post-exerciseOxygen consumption will be estimated using gas analyzer
Change in respiratory quotientChange from baseline to 15, 30, 45, 60 minutes during exercise and immediately post-exerciseRespiratory quotient will be estimated using gas analyzer

Secondary

MeasureTime frameDescription
Body weightBaselineBody weight will be estimated using beam balance scale
Body fat (%)BaselineBody fat will be measured by bioelectrical impedance analysis
Resting Heart RateBaselineResting heart rate will be measured using a heart rate sensor
Diastolic and systolic blood pressureBaselineDiastolic and systolic blood pressure will be measured using a manual sphygmomanometer
Maximal oxygen consumption (VO2max)BaselineVO2max will be measured using an automated open-circuit spirometer

Countries

Greece

Contacts

CONTACTAthanasios Jamurtas Z Jamurtas, Professor
ajamurt@uth.gr24310 47054
STUDY_DIRECTORAthanasios Z Jamurtas, Professor

University of Thessaly

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 30, 2026